文献速递浆细胞疾病

多发性骨髓瘤从诊断到维持治疗期间缺乏T细胞耗竭与抗原经历特征

Hallmarks of T-cell exhaustion and antigen experience are absent in multiple myeloma from diagnosis to maintenance therapy.
PubMed 文献 · Blood · 2025-01-01

研究采用单细胞多组学测序和质谱流式技术,对初诊多发性骨髓瘤患者从诊断到诱导治疗、自体干细胞移植及维持治疗的纵向骨髓和外周血样本进行分析,发现患者缺乏典型T细胞耗竭标志,未见终末耗竭或抗原驱动活化扩增的肿瘤经历T细胞。

要点

  • 初诊多发性骨髓瘤患者中未显著富集耗竭样CD8+ T细胞群。
  • 初诊患者外周血中活化T细胞频率增加,表型与克隆特征符合稳态细胞因子驱动活化。
  • 从诊断到维持治疗各时间点均无终末耗竭或抗原驱动扩增证据。

核心结论

  • 初诊多发性骨髓瘤患者在诊断至维持治疗各时间点均无证据显示存在具有终末耗竭和/或抗原驱动活化/扩增特征的肿瘤经历T细胞。

研究设计与样本

  • 研究对初诊多发性骨髓瘤患者的CD8+ T细胞区室进行深度分析,应用单细胞多组学测序和质谱流式技术。
  • 样本为从诊断到诱导治疗、自体干细胞移植和维持治疗时间点的纵向骨髓和外周血样本。

主要发现

  • 鉴定出一个耗竭样细胞群,该群缺乏多个经典耗竭标志,在初诊多发性骨髓瘤患者中未显著富集,且由小而非持续性的克隆型组成。
  • 初诊多发性骨髓瘤患者外周血中活化细胞群频率增加,其表型和克隆特征符合稳态、细胞因子驱动的活化。
  • 胞内细胞因子染色显示初诊多发性骨髓瘤患者缺乏功能上耗竭的T细胞。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dysregulation of the bone marrow (BM) niche in multiple myeloma (MM) alters the composition and state of resident immune cells, potentially impeding antitumor immunity. One common mechanism of immune inhibition in solid tumors is the induction of exhaustion in tumor-specific T cells. However, the extent of T-cell exhaustion is not well characterized in MM. As the specific mechanisms of immune evasion are critical for devising effective therapeutic strategies, we deeply profiled the CD8+ T-cell compartment of patients with newly diagnosed MM (NDMM) for evidence of T-cell activation and exhaustion. We applied single-cell multiomic sequencing and mass cytometry to longitudinal BM and peripheral blood (PB) samples taken from time points spanning from diagnosis to induction therapy, autologous stem cell transplant, and maintenance therapy. We identified an exhausted-like population that lacked several canonical exhaustion markers, was not significantly enriched in patients with NDMM, and consisted of small, nonpersistent clonotypes. We also observed an activated population with increased frequency in the PB of patients with NDMM exhibiting phenotypic and clonal features consistent with homeostatic, cytokine-driven activation. As an orthogonal measurement of T-cell exhaustion, we performed intracellular cytokine staining and found that patients with NDMM lacked functionally exhausted T cells. In summary, there was no evidence of "tumor-experienced" T cells displaying hallmarks of terminal exhaustion and/or antigen-driven activation/expansion in patients with NDMM at any time point.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Shasha C, Glass DR, Moelhman E, et al. Hallmarks of T-cell exhaustion and antigen experience are absent in multiple myeloma from diagnosis to maintenance therapy. Blood. 2025. PMID: 40163891. doi:10.1182/blood.2024025655

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。